GFR estimated with creatinine rather than cystatin C is more reflective of the true risk of adverse outcomes with low GFR in kidney transplant recipients

与使用胱抑素C估算的肾小球滤过率（GFR）相比，使用肌酐估算的GFR更能反映肾移植受者低GFR导致不良预后的真实风险。